Anika Therapeutics granted 3,360 restricted stock units (RSUs) to a newly hired non-executive employee on June 1, 2026. This grant was made under the company's 2021 Inducement Plan as a material inducement for accepting employment, in compliance with Nasdaq Listing Rule 5635(c)(4). The RSUs will vest in three equal installments over three years, contingent on continuous service. This move aligns with Anika's strategy to attract talent in its osteoarthritis pain management and regenerative solutions business.
Boralex Inc. has received final approval from the Superior Court of Québec for its arrangement with BIF Thunder Holdings Inc., jointly owned by Brookfield Infrastructure Fund V and Caisse de dépôt et placement du Québec. This approval follows shareho...
Arcutis Biotherapeutics awarded 44,000 restricted stock units to six newly hired employees as part of its 2022 Inducement Plan, approved by its board's Compensation Committee. These stock units vest over four years, with 25% vesting annually, conting...
Grabar Law Office is investigating claims against Badger Meter, Calix, New Era Energy & Digital, and Power Solutions International for alleged breaches of fiduciary duties by their officers and directors. The investigations stem from accusations of m...
The Organic Grower Summit is accepting nominations for its ninth annual Grower of the Year Award, sponsored by John Deere. The award honors leaders advancing organic farming through innovation and sustainability, with four finalists chosen to attend ...
Safetrust Inc. will present its commercial Aliro deployment at the Connectivity Standards Alliance's Unify conference in June 2026. The company's founder, Jason Hart, will join a panel discussing the readiness and benefits of Aliro for commercial env...
